Global Indemnity earnings missed by $0.08, revenue fell short of estimates

Global Indemnity (GBLI) reported Q3 EPS of $0.65, missing estimates by $0.08, with revenue at $102.77M, below the $124.01M consensus. The stock is down 27.86% over the past 3 months and 22.09% over the past year, according to Investing.com.

Original reporting
Published Nov 4, 2026, 2:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 3:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$GBLI
Bearish
medium confidence
Mentioned
$GBLI
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$GBLIBearishMed
01

Why it matters

The earnings miss may lead to short-term price decline, but longer-term fundamentals remain unclear.

02

Market read

Earnings miss for a small-cap insurer; relevance mainly to traders focused on micro-cap earnings.

03

What to watch

Potential cost controls or upcoming product launches not discussed in the brief release.

Relevance 6/10Novelty 6/10Timing: post-market reaction

Background

Global Indemnity is a micro-cap insurer listed on NASDAQ; the article provides its latest quarterly financials.

Company-level read

Ticker impact

$GBLIBearishMedium confidence
Context

Q3 earnings of $0.65 missed consensus $0.73 and revenue of $102.77M fell short of $124.01M estimates.

Expected impact

downward pressure as the market prices in the earnings miss

Evidence & confidence

The company reported results below expectations, which typically leads to a price decline.

Market effects

Limited impact; the company is a small-cap insurer with niche exposure.

Primarily affects U.S. small-cap segment.

Minimal

Counterpoint

If the miss is viewed as a temporary setback, the stock could be a buying opportunity at lower levels.

Key entities

  • Global Indemnity

    NASDAQ-listed insurer reporting Q3 results.

Related articles

$GBLIHigh

Global Indemnity Group, LLC Reports Financial Results for the three and nine months ended September 30, 2026

Global Indemnity Group, LLC (GBLI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For Immediate Release — November 4, 2026 Global Indemnity Group, LLC Reports Financial Results for the three and nine months ended September 30, 2026 Wilmington, Del., (November 4, 2026) — Global Indemnity Group, LLC (Nasdaq: GBLI) (the "Company") today reported fina

$GBLIMedAI 8/10

Global Indemnity (GBLI) Q2 2026 Earnings Call Transcript

Global Indemnity Group (GBLI) reported Q2 2026 net income of $11.1 million, or $0.76 per share, versus $10.3 million, or $0.71, a year earlier. Belmont Core gross written premiums were $117.3 million (+7%). Full-year guidance targets Belmont Core GWP about 15% above 2025. Investment income rose to $16.4 million.

$GBLIMed

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC (GBLI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For Immediate Release — August 5, 2026 Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026 Net income increased to $11.1 million, or $0.76 per share, growth of 8% for the quarter driven by a 53.8% loss ratio. Belmont

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.